Skip to content

Clinical trials

Completed Hematologic Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Completed Country / region: Italy Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20102
20121
20134
20144
20151
20161
20173
20187
20193
20203
20217
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Gruppo Italiano Trapianto di Midollo Osseo4
Seagen Inc.3
Abbott Medical Devices2
Genzyme, a Sanofi Company2
Swedish Orphan Biovitrum2
Vertex Pharmaceuticals Incorporated2
Amgen1
Azienda USL Reggio Emilia - IRCCS1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases40
Bone Marrow Diseases8
Blood Coagulation Disorders7
Genetic Diseases, Inborn7
Leukemia7
Hemorrhagic Disorders6
Myeloproliferative Disorders6
Anemia5
Coagulation Protein Disorders5
Hemophilia A5

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.